Veterinary Medicines

FUNGICONAZOL 200 MG TABLETS FOR DOGS

Authorised
  • Ketoconazole
Download as PDF

Product identification

Medicine name:
FUNGICONAZOL 200 MG TABLETS FOR DOGS
Canizol Vet. 200 mg tabletter
Active substance:
  • Ketoconazole
Target species:
  • Dog
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Ketoconazole
    200.00
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Tablet
Withdrawal period by route of administration:
  • Oral use
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ02AB02
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Denmark
Package description:
  • Cardboard box of 1 Aluminium/PVC/PE/PVDC blister containing 10 tablets each.
  • Cardboard box of 10 Aluminium/PVC/PE/PVDC blisters containing 10 tablets each.
  • Cardboard box of 9 Aluminium/PVC/PE/PVDC blisters containing 10 tablets each.
  • Cardboard box of 8 Aluminium/PVC/PE/PVDC blisters containing 10 tablets each.
  • Cardboard box of 7 Aluminium/PVC/PE/PVDC blisters containing 10 tablets each.
  • Cardboard box of 6 Aluminium/PVC/PE/PVDC blisters containing 10 tablets each.
  • Cardboard box of 5 Aluminium/PVC/PE/PVDC blisters containing 10 tablets each.
  • Cardboard box of 4 Aluminium/PVC/PE/PVDC blisters containing 10 tablets each.
  • Cardboard box of 3 Aluminium/PVC/PE/PVDC blisters containing 10 tablets each.
  • Cardboard box of 2 Aluminium/PVC/PE/PVDC blisters containing 10 tablets each.

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Dechra Regulatory B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Genera d.d.
  • Lelypharma B.V.
Responsible authority:
  • Danish Medicines Agency
Authorisation number:
  • 53096
Date of authorisation status change:
Reference member state:
  • France
Procedure number:
  • FR/V/0263/001
Concerned member states:
  • Austria
  • Belgium
  • Croatia
  • Czechia
  • Denmark
  • Estonia
  • Finland
  • Greece
  • Hungary
  • Iceland
  • Ireland
  • Italy
  • Latvia
  • Lithuania
  • Luxembourg
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Danish (, TABLETTER 200 MG OG 400 MG)
Published on: 7/04/2025
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."